Used in research settings to measure procollagen type I amino-terminal propeptide (PINP) levels in biological samples, serving as a biomarker for bone formation. Enables assessment of bone turnover in studies related to osteoporosis, metabolic bone diseases, and responses to bone-active therapies. The ELISA format allows for sensitive and specific quantification in serum or plasma, supporting both clinical research and drug development focused on bone metabolism.